Mesenchymal Stem Cells Market: By Source (Bone Marrow, Peripheral Blood, Lung Tissue, Umbilical Cord Blood, Amniotic Fluids, Adipose Tissues, and Synovial Tissues), By Applications (Injuries, Drug Discovery, Cardiovascular Infraction and Others), By End User (Clinical Research Organizations, Biotechnological Companies, Medical Research Institutes, and Hospitals), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Mesenchymal Stem Cells Market size was valued at USD 2.70 billion in 2022 and is poised to grow at a CAGR of 12.6% from 2023-2029. Owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market. 

Mesenchymal Stem Cells Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.6%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Mesenchymal Stem Cells Market Dynamics

However, it is expected that maintaining a similar level of quality and functionality in MSCs across batches may hinder market growth. For research and clinical applications, the reliability and repeatability of data is required to be maintained by standard and quality control processes. Furthermore, the main challenge to the market's growth will be expected to be the high expense of care and the dearth of therapeutic improvements related to the in vitro advantages of stem cells. 

Key Features of the Reports

  • Global market expanding at significant CAGR over 2023 to 2029 owing to rising prevalence of chronic disorders and rising advancements in technology for the development of new products and drugs
  • Based on application, cardiovascular segment of mesenchymal stem cells accounted for larger market revenue share in 2021 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

Mesenchymal Stem Cells Market Segmentation

By Source
  • Bone Marrow
  • Umbilical Cord Blood
  • Peripheral Blood
  • Lung Tissue
  • Synovial Tissues
  • Amniotic Fluids
  • Adipose Tissues
By Applications
  • Injuries
  • Drug Discovery
  • Cardiovascular Infraction
  • Others
By End user
  • Clinical research organizations
  • Biotechnological companies,
  • Medical research institutes,
  • Hospitals

Frequently Asked Questions

The key segments covered in the mesenchymal stem cells market are: by source, applications, end-user and geography

The mesenchymal stem cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The mesenchymal stem cells market key players are: Cell Applications, Inc. (USA), Celprogen, Inc. (USA), Cyagen US Inc. (USA), Genlantis, Inc. (USA), Lonza Group (Switzerland)

 
1.Executive Summary
2.Global Mesenchymal Stem Cells Market Introduction 
2.1.Global Mesenchymal Stem Cells Market  - Taxonomy
2.2.Global Mesenchymal Stem Cells Market  - Definitions
2.2.1.Source
2.2.2.Applications
2.2.3.End user
2.2.4.Region
3.Global Mesenchymal Stem Cells Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Mesenchymal Stem Cells Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Mesenchymal Stem Cells Market  By Source, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Bone Marrow
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Umbilical Cord Blood
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Peripheral Blood
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Lung Tissue
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Synovial Tissues
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Amniotic Fluids
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Adipose Tissues
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Mesenchymal Stem Cells Market  By Applications, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Injuries
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Drug Discovery
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardiovascular Infraction
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Mesenchymal Stem Cells Market  By End user, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Clinical research organizations
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnological companies,
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Medical research institutes,
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Hospitals
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Mesenchymal Stem Cells Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Bone Marrow
9.1.2.Umbilical Cord Blood
9.1.3.Peripheral Blood
9.1.4.Lung Tissue
9.1.5.Synovial Tissues
9.1.6.Amniotic Fluids
9.1.7.Adipose Tissues
9.2.  Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Injuries
9.2.2.Drug Discovery
9.2.3.Cardiovascular Infraction
9.2.4.Others
9.3.  End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Clinical research organizations
9.3.2.Biotechnological companies,
9.3.3.Medical research institutes,
9.3.4.Hospitals
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Bone Marrow
10.1.2.Umbilical Cord Blood
10.1.3.Peripheral Blood
10.1.4.Lung Tissue
10.1.5.Synovial Tissues
10.1.6.Amniotic Fluids
10.1.7.Adipose Tissues
10.2.  Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Injuries
10.2.2.Drug Discovery
10.2.3.Cardiovascular Infraction
10.2.4.Others
10.3.  End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Clinical research organizations
10.3.2.Biotechnological companies,
10.3.3.Medical research institutes,
10.3.4.Hospitals
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Bone Marrow
11.1.2.Umbilical Cord Blood
11.1.3.Peripheral Blood
11.1.4.Lung Tissue
11.1.5.Synovial Tissues
11.1.6.Amniotic Fluids
11.1.7.Adipose Tissues
11.2.  Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Injuries
11.2.2.Drug Discovery
11.2.3.Cardiovascular Infraction
11.2.4.Others
11.3.  End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Clinical research organizations
11.3.2.Biotechnological companies,
11.3.3.Medical research institutes,
11.3.4.Hospitals
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Bone Marrow
12.1.2.Umbilical Cord Blood
12.1.3.Peripheral Blood
12.1.4.Lung Tissue
12.1.5.Synovial Tissues
12.1.6.Amniotic Fluids
12.1.7.Adipose Tissues
12.2.  Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Injuries
12.2.2.Drug Discovery
12.2.3.Cardiovascular Infraction
12.2.4.Others
12.3.  End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Clinical research organizations
12.3.2.Biotechnological companies,
12.3.3.Medical research institutes,
12.3.4.Hospitals
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Mesenchymal Stem Cells Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Source Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Bone Marrow
13.1.2.Umbilical Cord Blood
13.1.3.Peripheral Blood
13.1.4.Lung Tissue
13.1.5.Synovial Tissues
13.1.6.Amniotic Fluids
13.1.7.Adipose Tissues
13.2.  Applications Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Injuries
13.2.2.Drug Discovery
13.2.3.Cardiovascular Infraction
13.2.4.Others
13.3.  End user Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Clinical research organizations
13.3.2.Biotechnological companies,
13.3.3.Medical research institutes,
13.3.4.Hospitals
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Cell Applications, Inc
14.2.2.Celprogen, Inc. 
14.2.3.Cyagen US Inc.
14.2.4.Genlantis, Inc.
14.2.5.Lonza Group
14.2.6.Mesoblast Limited 
14.2.7.MilliporeSigma 
14.2.8.Neuromics 
14.2.9.Orthofix International N.V.
14.2.10.PromoCell GmbH 
15. Research Methodology 
16. Appendix and Abbreviations 
  • Cell Applications, Inc
  • Celprogen, Inc. 
  • Cyagen US Inc.
  • Genlantis, Inc.
  • Lonza Group
  • Mesoblast Limited 
  • MilliporeSigma 
  • Neuromics 
  • Orthofix International N.V.
  • PromoCell GmbH